We are closer to ending pediatric HIV than at any point in history. And yet in 2024, 120,000 children acquired HIV — every case preventable. Children are 3% of people living with HIV but account for 12% of all HIV-related deaths. Without timely diagnosis and treatment, half will not reach their second birthday. The global HIV field is excited about innovation — and rightly so. But innovation alone will not end pediatric HIV. Globally, nearly 58% of new infections in children occur because the mother was never diagnosed or never started ART. Maternal acquisition during pregnancy and breastfeeding accounts for another 25% — where long-acting PrEP has genuine potential, but only if women stay on it. Early data from countries like Malawi show that adherence and retention on lenacapavir remain real challenges. The foundational gap must be confronted alongside the innovation agenda. The funding disruptions of the past year have aggravated these gaps. New infections in children had declined 62% since 2010. That progress is now in jeopardy. This session will examine where the gaps are, what the evidence tells us about fixing them, and what the global HIV community can commit to today.
Children can’t wait: From funding crisis to foundational fixes: What it will actually take to end pediatric HIV
Chair
Roland Van De Ven
Elizabeth Glaser Pediatric AIDS Foundation
Speakers
Roland Van De Ven
Elizabeth Glaser Pediatric AIDS Foundation
Welcome, introductions and framing of the session
- presentation-slides_439.pptx (149.65 MB)
Doris Kananu Macharia
Elizabeth Glaser Pediatric AIDS Foundation
Opening frame: the Generation Zero goal and the foundational challenge
Prosper Faustine Njau
Ministry of Health, Tanzania Mainland
The government view: strengthening and sustaining ANC uptake, maternal ART initiation and PMTCT retention
Harerimana Ismail
Elizabeth Glaser Pediatric AIDS Foundation
What community knows: peer-led models for maternal and adolescent retention
Friday Saidi
UNC Project Malawi
Roland Van De Ven
Elizabeth Glaser Pediatric AIDS Foundation
Doris Kananu Macharia
Elizabeth Glaser Pediatric AIDS Foundation
Prosper Faustine Njau
Ministry of Health, Tanzania Mainland
Harerimana Ismail
Elizabeth Glaser Pediatric AIDS Foundation
Moderated discussion: foundational fixes vs innovation adoption in a shifting financing landscape